March 10, 2026

LifeStance Health Group, Inc. (LFST) Investor Outlook: Exploring a 42% Potential Upside in Mental Health Services

LifeStance Health Group, Inc. (LFST), a prominent player in the healthcare sector, operates within the medical care facilities industry, focusing on mental health services across the..

Apogee Therapeutics, Inc. (APGE) Stock Analysis: A 41% Potential Upside in the Biotech Sector

Apogee Therapeutics, Inc. (NASDAQ: APGE) is making waves in the biotechnology sector with its promising pipeline of novel biologics aimed at treating a range of inflammatory..

AtriCure, Inc. (ATRC) Stock Analysis: Exploring a 68% Potential Upside in the Healthcare Sector

AtriCure, Inc. (NASDAQ: ATRC), a notable player in the healthcare sector, stands out as an intriguing opportunity for investors with its robust product portfolio and promising..

Alphatec Holdings, Inc. (ATEC) Stock Analysis: Investors Eye Nearly 89% Potential Upside with Strong Buy Ratings

Alphatec Holdings, Inc. (ATEC), a key player in the medical devices sector, is capturing investor attention with its innovative approach to spinal disorder treatments and a..

Centessa Pharmaceuticals (CNTA): Exploring a 51.95% Potential Upside in the Biotech Sector

Centessa Pharmaceuticals plc (NASDAQ: CNTA) is making waves in the biotechnology industry with its innovative approach to drug development. Headquartered in Altrincham, United Kingdom, Centessa is..

Travere Therapeutics, Inc. (TVTX) Investor Outlook: A 47% Potential Upside Beckons

For investors with a penchant for the healthcare sector, particularly in the biotechnology industry, Travere Therapeutics, Inc. (TVTX) presents an intriguing opportunity. As a biopharmaceutical company..

Supernus Pharmaceuticals, Inc. (SUPN) Stock Analysis: A 16.61% Potential Upside Awaits Investors

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN), a key player in the healthcare sector specializing in the development and commercialization of treatments for central nervous system (CNS) diseases,..

Haemonetics Corporation (HAE) Stock Analysis: Unpacking the 37% Potential Upside

Haemonetics Corporation (NYSE: HAE), a stalwart in the healthcare sector, specifically within the medical devices industry, is drawing investor attention with its compelling growth potential. With..

Denali Therapeutics Inc. (DNLI) Stock Analysis: Navigating the Biotech Terrain with a 54.52% Potential Upside

Denali Therapeutics Inc. (NASDAQ: DNLI), a prominent player in the biotechnology sector, is making waves with its innovative approach to treating neurodegenerative and lysosomal storage diseases...

Tandem Diabetes Care, Inc. (TNDM) Investor Outlook: Assessing a 41.72% Potential Upside

As the medical devices sector continues to innovate, Tandem Diabetes Care, Inc. (NASDAQ: TNDM) stands out with its focus on improving the lives of diabetes patients..

Schrodinger, Inc. (SDGR) Investor Outlook: Exploring an 81% Potential Upside Amidst Healthcare Innovations

Schrodinger, Inc. (NASDAQ: SDGR) presents a compelling opportunity for investors seeking exposure to the healthcare sector, particularly within the realm of health information services. Headquartered in..

IDEAYA Biosciences, Inc. (IDYA) Stock Analysis: Unraveling a 42.71% Potential Upside in Precision Medicine

IDEAYA Biosciences, Inc. (NASDAQ: IDYA) has captured the attention of investors with its focus on precision medicine within the biotechnology sector. Headquartered in South San Francisco,..

Twist Bioscience Corporation (TWST) Stock Analysis: Exploring Growth Potential Amidst a 16.9% Revenue Surge

Twist Bioscience Corporation (NASDAQ: TWST), a pioneer in synthetic DNA production, remains a compelling investment opportunity in the healthcare sector, particularly within diagnostics and research. Headquartered..

Addus HomeCare Corporation (ADUS): Investor Outlook with a 36% Potential Upside

Addus HomeCare Corporation (NASDAQ: ADUS) stands out as a compelling player in the healthcare sector, specifically within the Medical Care Facilities industry. With a market capitalization..

PACS Group, Inc. (PACS) Investor Outlook: A Promising 36% Upside in the Healthcare Sector

PACS Group, Inc. (NASDAQ: PACS) has emerged as a noteworthy player in the healthcare sector, specifically within the medical care facilities industry. Focused on providing skilled..

ACADIA Pharmaceuticals Inc. (ACAD) Stock Analysis: Exploring a Promising 41% Upside Potential

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) stands out in the biotechnology sector, with a focus on innovative solutions for neurological and rare diseases. With a market capitalization..

Agios Pharmaceuticals, Inc. (AGIO) Stock Analysis: Biotech Growth with a 39.77% Upside Potential

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) presents a compelling opportunity for investors with its strong growth trajectory in the biotechnology sector, a promising pipeline of drug candidates,..

Organon & Co. (OGN) Stock Analysis: Navigating the 37.83% Potential Upside Amidst Market Challenges

Organon & Co. (NYSE: OGN), a healthcare company specializing in women’s health solutions and biosimilars, presents an intriguing opportunity for investors willing to navigate its current..

Tarsus Pharmaceuticals, Inc. (TARS) Stock Analysis: Exploring a 26.69% Potential Upside in the Biotech Sector

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) is carving out a niche in the biotechnology sector with its innovative approach to eye care and disease prevention. Investors are..

HUTCHMED (China) Limited (HCM) Stock Analysis: Navigating the 55.60% Potential Upside Amidst Revenue Challenges

HUTCHMED (China) Limited (HCM) is attracting significant attention from investors as it boasts a promising potential upside of 55.60% according to analysts’ average target price. Despite..

Search

Funds

March 10, 2026

Search

Funds

March 10, 2026

FTSE 100

Funds